Peter S. Hoffmeister, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Sinus | 1 | 2012 | 87 | 0.400 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2012 | 124 | 0.380 |
Why?
|
Cardiac Pacing, Artificial | 3 | 2008 | 847 | 0.320 |
Why?
|
Electric Countershock | 3 | 2021 | 533 | 0.300 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2023 | 525 | 0.280 |
Why?
|
Mediastinum | 1 | 2007 | 267 | 0.270 |
Why?
|
Tomography, Spiral Computed | 1 | 2007 | 279 | 0.260 |
Why?
|
Heart Atria | 2 | 2007 | 1342 | 0.240 |
Why?
|
Ultrasonography, Interventional | 1 | 2012 | 1480 | 0.230 |
Why?
|
Defibrillators, Implantable | 4 | 2021 | 1441 | 0.220 |
Why?
|
Arrhythmias, Cardiac | 3 | 2021 | 2265 | 0.200 |
Why?
|
Electrodes, Implanted | 1 | 2006 | 821 | 0.200 |
Why?
|
Atrial Fibrillation | 6 | 2014 | 5003 | 0.180 |
Why?
|
Heart Failure | 4 | 2023 | 10793 | 0.140 |
Why?
|
Device Removal | 1 | 2021 | 648 | 0.130 |
Why?
|
Catheter Ablation | 2 | 2007 | 2737 | 0.120 |
Why?
|
Pacemaker, Artificial | 2 | 2012 | 813 | 0.120 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1408 | 0.120 |
Why?
|
United States Department of Veterans Affairs | 1 | 2018 | 873 | 0.120 |
Why?
|
Amiodarone | 2 | 2012 | 211 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1542 | 0.110 |
Why?
|
Esophagus | 2 | 2007 | 1017 | 0.100 |
Why?
|
Tachycardia, Ventricular | 2 | 2012 | 1271 | 0.090 |
Why?
|
Equipment Failure | 1 | 2012 | 580 | 0.090 |
Why?
|
Electrocardiography | 3 | 2012 | 6426 | 0.090 |
Why?
|
Syncope | 1 | 2012 | 431 | 0.090 |
Why?
|
Prosthesis Implantation | 1 | 2012 | 640 | 0.070 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2012 | 851 | 0.070 |
Why?
|
Heart Rate | 2 | 2021 | 4095 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2008 | 1129 | 0.070 |
Why?
|
Causality | 1 | 2012 | 1262 | 0.070 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 271 | 0.070 |
Why?
|
Aortography | 1 | 2007 | 429 | 0.070 |
Why?
|
Patient Admission | 1 | 2012 | 1383 | 0.060 |
Why?
|
Anaphylaxis | 1 | 2012 | 747 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2277 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2008 | 2881 | 0.060 |
Why?
|
Angina Pectoris | 1 | 2007 | 976 | 0.060 |
Why?
|
Motor Activity | 1 | 2013 | 2719 | 0.050 |
Why?
|
Ventricular Fibrillation | 1 | 2005 | 539 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3268 | 0.050 |
Why?
|
Treatment Outcome | 8 | 2023 | 62693 | 0.050 |
Why?
|
Fluoroscopy | 1 | 2006 | 915 | 0.050 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2044 | 0.050 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4220 | 0.050 |
Why?
|
Contrast Media | 1 | 2012 | 5293 | 0.040 |
Why?
|
Ventricular Function, Left | 2 | 2021 | 3620 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2007 | 1909 | 0.040 |
Why?
|
Stroke Volume | 2 | 2021 | 4941 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2008 | 2146 | 0.040 |
Why?
|
Aged | 10 | 2023 | 162698 | 0.040 |
Why?
|
Male | 13 | 2023 | 349022 | 0.040 |
Why?
|
Risk Assessment | 2 | 2021 | 23294 | 0.040 |
Why?
|
Veterans Health | 1 | 2018 | 216 | 0.030 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2012 | 788 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2006 | 4560 | 0.030 |
Why?
|
Humans | 16 | 2023 | 739398 | 0.030 |
Why?
|
Action Potentials | 1 | 2021 | 1813 | 0.030 |
Why?
|
Middle Aged | 9 | 2021 | 212863 | 0.030 |
Why?
|
Risk Factors | 5 | 2021 | 71974 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12328 | 0.030 |
Why?
|
Time Factors | 2 | 2018 | 40050 | 0.020 |
Why?
|
Israel | 1 | 2012 | 794 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 20913 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 53037 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2008 | 177 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3564 | 0.020 |
Why?
|
Female | 8 | 2021 | 378853 | 0.020 |
Why?
|
Sotalol | 1 | 2005 | 49 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 643 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2007 | 584 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12237 | 0.020 |
Why?
|
Injections | 1 | 2007 | 837 | 0.020 |
Why?
|
Comorbidity | 1 | 2018 | 10362 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20055 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1833 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7690 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2005 | 484 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2007 | 766 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 845 | 0.010 |
Why?
|
Exercise Test | 1 | 2008 | 2069 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9846 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1238 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2687 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2014 | 13880 | 0.010 |
Why?
|
Adult | 2 | 2012 | 213394 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14740 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5058 | 0.010 |
Why?
|
Quality of Life | 2 | 2008 | 12640 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15153 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2007 | 8605 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2012 | 57650 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 76631 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19811 | 0.010 |
Why?
|
Myocardium | 1 | 2007 | 4788 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2007 | 11985 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4035 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 40389 | 0.010 |
Why?
|
United States | 1 | 2018 | 69573 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2006 | 8977 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 85405 | 0.000 |
Why?
|